463 related articles for article (PubMed ID: 28424163)
21. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.
Genovese G; Kähler AK; Handsaker RE; Lindberg J; Rose SA; Bakhoum SF; Chambert K; Mick E; Neale BM; Fromer M; Purcell SM; Svantesson O; Landén M; Höglund M; Lehmann S; Gabriel SB; Moran JL; Lander ES; Sullivan PF; Sklar P; Grönberg H; Hultman CM; McCarroll SA
N Engl J Med; 2014 Dec; 371(26):2477-87. PubMed ID: 25426838
[TBL] [Abstract][Full Text] [Related]
22. Spectrum of hematological malignancies and peripheral cytopenias.
Jha A
J Nepal Health Res Counc; 2013 Sep; 11(25):273-8. PubMed ID: 24908530
[TBL] [Abstract][Full Text] [Related]
23. Clonal cytopenias of undetermined significance: potential predictor of myeloid malignancies?
Vobugari N; Heuston C; Lai C
Clin Adv Hematol Oncol; 2022 Jun; 20(6):375-383. PubMed ID: 35731608
[TBL] [Abstract][Full Text] [Related]
24. Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome.
Kulasekararaj AG; Jiang J; Smith AE; Mohamedali AM; Mian S; Gandhi S; Gaken J; Czepulkowski B; Marsh JC; Mufti GJ
Blood; 2014 Oct; 124(17):2698-704. PubMed ID: 25139356
[TBL] [Abstract][Full Text] [Related]
25. Mutational landscape of patients with acute myeloid leukemia or myelodysplastic syndromes in the context of RUNX1 mutation.
Wang K; Zhou F; Cai X; Chao H; Zhang R; Chen S
Hematology; 2020 Dec; 25(1):211-218. PubMed ID: 32476595
[No Abstract] [Full Text] [Related]
26. [Significance of Targeted Sequencing Assay for Patients with Suspected Myeloid Malignancies].
Zhang LJ; Shi YY; Chen Y; Deng Y; Ding YH; Li Z; Chen KK; Ding BH; Wang CL; Yu L; He ZM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1985-1990. PubMed ID: 33283730
[TBL] [Abstract][Full Text] [Related]
27. Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia.
Yoshizato T; Dumitriu B; Hosokawa K; Makishima H; Yoshida K; Townsley D; Sato-Otsubo A; Sato Y; Liu D; Suzuki H; Wu CO; Shiraishi Y; Clemente MJ; Kataoka K; Shiozawa Y; Okuno Y; Chiba K; Tanaka H; Nagata Y; Katagiri T; Kon A; Sanada M; Scheinberg P; Miyano S; Maciejewski JP; Nakao S; Young NS; Ogawa S
N Engl J Med; 2015 Jul; 373(1):35-47. PubMed ID: 26132940
[TBL] [Abstract][Full Text] [Related]
28. [The cause of cytopenia of undetermined significance can often be found by using next generation sequencing].
Hansen JW; Husby S; Grønbæk K
Ugeskr Laeger; 2017 Jun; 179(25):. PubMed ID: 28648154
[TBL] [Abstract][Full Text] [Related]
29. Impact of the variant allele frequency of ASXL1, DNMT3A, JAK2, TET2, TP53, and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia.
Sasaki K; Kanagal-Shamanna R; Montalban-Bravo G; Assi R; Jabbour E; Ravandi F; Kadia T; Pierce S; Takahashi K; Nogueras Gonzalez G; Patel K; Soltysiak KA; Cortes J; Kantarjian HM; Garcia-Manero G
Cancer; 2020 Feb; 126(4):765-774. PubMed ID: 31742675
[TBL] [Abstract][Full Text] [Related]
30. Clonal Hematopoiesis of Indeterminate Potential.
Heuser M; Thol F; Ganser A
Dtsch Arztebl Int; 2016 May; 113(18):317-22. PubMed ID: 27215596
[TBL] [Abstract][Full Text] [Related]
31. Age-related clonal hematopoiesis associated with adverse outcomes.
Jaiswal S; Fontanillas P; Flannick J; Manning A; Grauman PV; Mar BG; Lindsley RC; Mermel CH; Burtt N; Chavez A; Higgins JM; Moltchanov V; Kuo FC; Kluk MJ; Henderson B; Kinnunen L; Koistinen HA; Ladenvall C; Getz G; Correa A; Banahan BF; Gabriel S; Kathiresan S; Stringham HM; McCarthy MI; Boehnke M; Tuomilehto J; Haiman C; Groop L; Atzmon G; Wilson JG; Neuberg D; Altshuler D; Ebert BL
N Engl J Med; 2014 Dec; 371(26):2488-98. PubMed ID: 25426837
[TBL] [Abstract][Full Text] [Related]
32. Routine clinical mutation profiling using next generation sequencing and a customized gene panel improves diagnostic precision in myeloid neoplasms.
Bartels S; Schipper E; Hasemeier B; Kreipe H; Lehmann U
Oncotarget; 2016 May; 7(21):30084-93. PubMed ID: 27029036
[TBL] [Abstract][Full Text] [Related]
33. When are idiopathic and clonal cytopenias of unknown significance (ICUS or CCUS)?
Osman AEWG
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):399-404. PubMed ID: 34889436
[TBL] [Abstract][Full Text] [Related]
34. BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.
Damm F; Chesnais V; Nagata Y; Yoshida K; Scourzic L; Okuno Y; Itzykson R; Sanada M; Shiraishi Y; Gelsi-Boyer V; Renneville A; Miyano S; Mori H; Shih LY; Park S; Dreyfus F; Guerci-Bresler A; Solary E; Rose C; Cheze S; Prébet T; Vey N; Legentil M; Duffourd Y; de Botton S; Preudhomme C; Birnbaum D; Bernard OA; Ogawa S; Fontenay M; Kosmider O
Blood; 2013 Oct; 122(18):3169-77. PubMed ID: 24047651
[TBL] [Abstract][Full Text] [Related]
35. MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance.
Kwok B; Hall JM; Witte JS; Xu Y; Reddy P; Lin K; Flamholz R; Dabbas B; Yung A; Al-Hafidh J; Balmert E; Vaupel C; El Hader C; McGinniss MJ; Nahas SA; Kines J; Bejar R
Blood; 2015 Nov; 126(21):2355-61. PubMed ID: 26429975
[TBL] [Abstract][Full Text] [Related]
36. Excellent Prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related Mutations.
Polprasert C; Niparuck P; Rattanathammethee T; Chuncharunee S; Kobbuaklee S; Songserm K; Suksusut A; Trithiphen S; Lanamtieng T; Kongkiatkamon S; Chanswangphuwana C; Lawasut P; Bunworasate U; Rojnuckarin P
Clin Lymphoma Myeloma Leuk; 2022 May; 22(5):e293-e299. PubMed ID: 34840089
[TBL] [Abstract][Full Text] [Related]
37. Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group.
Faivre L; Guardiola P; Lewis C; Dokal I; Ebell W; Zatterale A; Altay C; Poole J; Stones D; Kwee ML; van Weel-Sipman M; Havenga C; Morgan N; de Winter J; Digweed M; Savoia A; Pronk J; de Ravel T; Jansen S; Joenje H; Gluckman E; Mathew CG
Blood; 2000 Dec; 96(13):4064-70. PubMed ID: 11110674
[TBL] [Abstract][Full Text] [Related]
38. Capture-based targeted sequencing using a T-cell control in myeloid malignancies and idiopathic cytopenias.
Pietka G; De Lord C; Matthias G; Cheung B; Atwal S; Furtado M; Cullis J; Grey-Davies L; Narayanan S; McGregor A; Kilner M; Bosworth J; McMullin MF; Coats T; Parcharidou A; Cavenagh J; Byrne J; Iyengar S; Mohammed K; Cross N; Hubank M; Ribeiro S; Khorashad J; Wren D; O'Connor S; Taussig D
Br J Haematol; 2024 Apr; 204(4):1325-1334. PubMed ID: 38462984
[TBL] [Abstract][Full Text] [Related]
39. Clonal cytopenia of undetermined significance (CCUS) with dysplasia is enriched for MDS-type molecular findings compared to CCUS without dysplasia.
Jajosky AN; Sadri N; Meyerson HJ; Oduro KA; Kelkar A; Fitzgerald B; Tomlinson B; Moore EM; Beck RC
Eur J Haematol; 2021 Apr; 106(4):500-507. PubMed ID: 33386622
[TBL] [Abstract][Full Text] [Related]
40. Clonal leukemic evolution in myelodysplastic syndromes with TET2 and IDH1/2 mutations.
Lin TL; Nagata Y; Kao HW; Sanada M; Okuno Y; Huang CF; Liang DC; Kuo MC; Lai CL; Lee EH; Shih YS; Tanaka H; Shiraishi Y; Chiba K; Lin TH; Wu JH; Miyano S; Ogawa S; Shih LY
Haematologica; 2014 Jan; 99(1):28-36. PubMed ID: 23996483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
